[ad_1]
SUS proposes a new treatment for patients with retinal degeneration
Photo: Marcello Casal Jr./Agência Brasil
The Brazilian Ministry Health has announced that it has extended treatment. patients with age-related macular degeneration through the provision of antigenic drug and optical coherence tomography. According to the record, both incorporations are important for the early detection and treatment of previously confirmed cases, stabilizing the course of the disease. Macular degeneration reaches the central part of the retina and causes progressive loss of central vision.
The two new procedures should be addressed to patients from the age of 60, in accordance with the clinical protocol and therapeutic principles of age-related macular degeneration. The antigenic drug is injectable and can be administered in one or both eyes, with a minimum interval of 15 days between one eye and the other. Optical coherence tomography is a non-invasive diagnostic test for the disease of both eyes. The goal is to detect microscopic signs of early retinal changes
Disease
Age-related macular degeneration is a progressive disease that affects the central area of the retina, where images are formed. , invariably causing vision loss. central The main risk factor is age. The disease can be clbadified as dry, responsible in most cases (85% to 90%) or humid (10% to 15%).
Loading …
Revise the following article
[ad_2]
Source link
